These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16868222)

  • 1. Overview of oral modified-release opioid products for the management of chronic pain.
    Amabile CM; Bowman BJ
    Ann Pharmacother; 2006; 40(7-8):1327-35. PubMed ID: 16868222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral oxymorphone for pain management.
    Chamberlin KW; Cottle M; Neville R; Tan J
    Ann Pharmacother; 2007 Jul; 41(7):1144-52. PubMed ID: 17595308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid formulations: tailoring to the needs in chronic pain.
    Reder RF
    Eur J Pain; 2001; 5 Suppl A():109-11. PubMed ID: 11798229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the economic and health consequences of managing chronic osteoarthritis pain with opioids in Germany: comparison of extended-release oxycodone and OROS hydromorphone.
    Ward A; Bozkaya D; Fleischmann J; Dubois D; Sabatowski R; Caro JJ
    Curr Med Res Opin; 2007 Oct; 23(10):2333-45. PubMed ID: 17697453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs.
    Coluzzi F; Mattia C
    Minerva Anestesiol; 2010 Dec; 76(12):1072-84. PubMed ID: 21102402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxycodone. Pharmacological profile and clinical data in chronic pain management.
    Coluzzi F; Mattia C
    Minerva Anestesiol; 2005; 71(7-8):451-60. PubMed ID: 16012419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid conversions in acute care.
    Patanwala AE; Duby J; Waters D; Erstad BL
    Ann Pharmacother; 2007 Feb; 41(2):255-66. PubMed ID: 17299011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extended release oxycodone. An oral opioid analgesic for cancer patients with chronic pain].
    Taeron C
    Rev Infirm; 2002 Nov; (85):47-9. PubMed ID: 12510533
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain.
    Gallagher RM; Welz-Bosna M; Gammaitoni A
    Pain Med; 2007; 8(1):71-4. PubMed ID: 17244106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nociceptive cancer pain in adult patients: statement about guidelines related to the use of antinociceptive medicine].
    Binhas M; Krakowski I; Marty J
    Ann Fr Anesth Reanim; 2007 Jun; 26(6):502-15. PubMed ID: 17560755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose controlled-release oxycodone in hospice care.
    Bercovitch M; Adunsky A
    J Pain Palliat Care Pharmacother; 2006; 20(4):33-9. PubMed ID: 17182504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of a long-acting OROS hydromorphone formulation.
    Turgeon J; Gröning R; Sathyan G; Thipphawong J; Richarz U
    Expert Opin Drug Deliv; 2010 Jan; 7(1):137-44. PubMed ID: 19961358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipation.
    Meissner W; Leyendecker P; Mueller-Lissner S; Nadstawek J; Hopp M; Ruckes C; Wirz S; Fleischer W; Reimer K
    Eur J Pain; 2009 Jan; 13(1):56-64. PubMed ID: 18762438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oxycodone: a strong opioid in the treatment of patients with arthritis].
    Grazio S; Anić B; Bilusić M
    Reumatizam; 2006; 53(2):59-62. PubMed ID: 17580556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain management of opioid-treated cancer patients in hospital settings in Denmark.
    Lundorff L; Peuckmann V; Sjøgren P
    Acta Anaesthesiol Scand; 2008 Jan; 52(1):137-42. PubMed ID: 18005379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic treatment of opioid-induced sedation in chronic pain.
    Reissig JE; Rybarczyk AM
    Ann Pharmacother; 2005 Apr; 39(4):727-31. PubMed ID: 15755795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain.
    Barkin RL
    Am J Ther; 2008; 15(2):157-66. PubMed ID: 18356636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.